• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Strata Critical Medical to Present at the 2025 Jefferies Industrials Conference

    8/29/25 12:00:00 PM ET
    $BLDE
    Transportation Services
    Consumer Discretionary
    Get the next $BLDE alert in real time by email

    NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), formerly known as Blade Air Mobility, Inc. (NASDAQ:BLDE) today announced that Will Heyburn, Co-Chief Executive Officer and Chief Financial Officer, will present at the 2025 Jefferies Industrials Conference on Thursday, Sept 4, 2025 at 11:30am ET. A webcast of the event will be available at the link here. A replay will be available shortly after the conclusion of the presentation on the investor relations section of the Company's website at https://ir.stratacritical.com/news-events.

    About Strata Critical Medical

    Strata Critical Medical provides time critical logistics solutions and specialized medical services to healthcare providers across the United States, strategically expanding its portfolio of services through acquisition and organic growth. Strata's subsidiary, Trinity Medical Solutions, is an industry leader in air and ground transportation of human organs for transplant, leveraging Strata's asset-light platform to reliably and efficiently deliver logistics solutions to its customers across the United States.

    For more information, visit www.stratacritical.com

    Forward-Looking Statements

    This press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts and may be identified by the use of words such as "will", "anticipate", "believe", "could", "continue", "expect", "estimate", "may", "plan", "outlook", "future", "target", and "project" and other similar expressions and the negatives of those terms. These statements, which involve risks and uncertainties, relate to the sale of Strata's Passenger business, analyses and other information that are based on forecasts of future results and estimates of amounts not yet determinable and may also relate to Strata's future prospects, developments and business strategies. In particular, such forward-looking statements include statements concerning the impact and anticipated benefits of the sale of Strata's Passenger business (including the receipt of any contingent consideration), the impact of such divestiture on Strata's financial performance and liquidity outlook, Strata's future plans and business strategies, financial and operating performance (including the discussion of financial and liquidity outlook and guidance for 2025 and beyond), the composition and performance of its fleet, results of operations, industry environment and growth opportunities and new product lines and partnerships. These statements are based on management's current expectations and beliefs, as well as a number of assumptions concerning future events. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance.

    Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Strata's control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied in forward-looking statements include: unexpected costs, charges, or expenses resulting from the proposed divestiture; any failure to realize the anticipated efficiencies and benefits of such transaction; fluctuations in the value of any equity issued to Strata in the transaction; our continued incurrence of significant losses; failure of the markets for our offerings to grow as expected, or at all; our ability to successfully enter new markets and launch new routes and services; any adverse publicity stemming from accidents involving small aircraft, helicopters or charter flights and, in particular, any accidents involving our third-party operators; the impact of the recently completed sale of our Passenger business ; any change to the ownership of our aircraft and the challenges related thereto; the effects of competition; harm to our reputation and brand; our ability to provide high-quality customer support; our ability to maintain a high daily aircraft usage rate; changes in economic conditions; impact of natural disasters, outbreaks and pandemics, economic, social, weather, geopolitical, growth constraints, and regulatory conditions or other circumstances on metropolitan areas and airports where we have geographic concentration; the effects of climate change, including potential increased impacts of severe weather and regulatory activity; the availability of aircraft fuel; our ability to address system failures, defects, errors, or vulnerabilities in our website, applications, backend systems or other technology systems or those of third-party technology providers; interruptions or security breaches of our information technology systems; our placements within mobile applications; our ability to protect our intellectual property rights; our use of open source software; our ability to expand and maintain our infrastructure network; our ability to access additional funding; our ability to identify, complete and successfully integrate future acquisitions; our ability to manage our growth; increases in insurance costs or reductions in insurance coverage; the loss of key members of our management team; our ability to maintain our company culture; our reliance on contractual relationships with certain transplant centers and Organ Procurement Organizations; effects of fluctuating financial results; our reliance on third-party operators; the availability of third-party operators; disruptions to third-party operators; increases in insurance costs or reductions in insurance coverage for our third-party aircraft operators; the possibility that our third-party aircraft operators may illegally, improperly or otherwise inappropriately operate our branded aircraft; our reliance on third-party web service providers; changes in our regulatory environment; risks and impact of any litigation we may be subject to; regulatory obstacles in local governments; the expansion of domestic and foreign privacy and security laws; the expansion of environmental regulations; our ability to remediate any material weaknesses or maintain internal controls over financial reporting; our ability to maintain effective internal controls and disclosure controls; changes in the fair value of our warrants; and other factors beyond our control. Additional factors can be found in our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, each as filed with the U.S. Securities and Exchange Commission. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect us. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, and Strata undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, changes in expectations, future events or otherwise.

    Contacts

    Mathew Schneider

    [email protected]



    Primary Logo

    Get the next $BLDE alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BLDE

    DatePrice TargetRatingAnalyst
    2/26/2025$6.50Buy
    Lake Street
    7/18/2023$13.00Buy
    Ladenburg Thalmann
    7/17/2023$13.00Buy
    Ladenburg Thalmann
    9/28/2021$14.00Outperform
    Oppenheimer
    9/9/2021$16.00Overweight
    JP Morgan
    9/2/2021$15.00Buy
    Deutsche Bank
    9/1/2021$15.00Buy
    Deutsche Bank
    8/26/2021$14.00Outperform
    Credit Suisse
    More analyst ratings

    $BLDE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Strata Critical Medical to Present at the 2025 Jefferies Industrials Conference

    NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), formerly known as Blade Air Mobility, Inc. (NASDAQ:BLDE) today announced that Will Heyburn, Co-Chief Executive Officer and Chief Financial Officer, will present at the 2025 Jefferies Industrials Conference on Thursday, Sept 4, 2025 at 11:30am ET. A webcast of the event will be available at the link here. A replay will be available shortly after the conclusion of the presentation on the investor relations section of the Company's website at https://ir.stratacritical.com/news-events. About Strata Critical Medical Strata Critical Medical provides time critical logistics solu

    8/29/25 12:00:00 PM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    Blade Completes Sale of Passenger Business and Planned Name Change to Strata Critical Medical, Begins Trading Under Ticker Symbol SRTA

    NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), formerly known as Blade Air Mobility, Inc. (NASDAQ:BLDE), today announced the successful closing of the previously announced divestiture of the Company's Passenger business to Joby Aviation, Inc. (NYSE:JOBY). Joby has elected to pay the up-front consideration in stock. The Company may receive up to an additional $35.0 million in consideration based on maintaining certain employee retention and financial performance targets during the 18 and 12 months, respectively, following today's closing, as well as the release of up to $10.0 million in indemnity holdbacks, payable in cas

    8/29/25 8:30:00 AM ET
    $BLDE
    $JOBY
    Transportation Services
    Consumer Discretionary
    Aerospace
    Industrials

    Blade Air Mobility Sets Timing for Name Change to Strata Critical Medical and Commencement of Trading Under the New Ticker Symbol "SRTA"

    NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (NASDAQ:BLDE, "Blade" or the "Company")), today confirmed that the previously announced change of its legal name to Strata Critical Medical, Inc is expected to occur this week. The change is intended to reflect the Company's plan to focus on providing mission critical logistics and medical services to hospitals and healthcare providers throughout the country following the closing of the previously announced agreement to sell Blade's Passenger business to Joby Aviation, Inc. (NYSE:JOBY). The name change is expected to occur on August 28, 2025. The Company further anticipates that commencing with the opening of trading on

    8/27/25 8:00:00 AM ET
    $BLDE
    $JOBY
    Transportation Services
    Consumer Discretionary
    Aerospace
    Industrials

    $BLDE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Love Reginald bought $15,197 worth of shares (5,091 units at $2.98), increasing direct ownership by 9% to 62,628 units (SEC Form 4)

    4 - Blade Air Mobility, Inc. (0001779128) (Issuer)

    6/12/24 5:42:48 PM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    Director Borthwick John bought $22,996 worth of shares (7,743 units at $2.97), increasing direct ownership by 10% to 83,817 units (SEC Form 4)

    4 - Blade Air Mobility, Inc. (0001779128) (Issuer)

    6/12/24 5:42:19 PM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    Affeldt Eric bought $159,840 worth of shares (50,000 units at $3.20) (SEC Form 4)

    4 - Blade Air Mobility, Inc. (0001779128) (Issuer)

    11/14/23 2:43:06 PM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    $BLDE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on Blade Air Mobility with a new price target

    Lake Street initiated coverage of Blade Air Mobility with a rating of Buy and set a new price target of $6.50

    2/26/25 8:08:46 AM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    Ladenburg Thalmann initiated coverage on Blade Air Mobility with a new price target

    Ladenburg Thalmann initiated coverage of Blade Air Mobility with a rating of Buy and set a new price target of $13.00

    7/18/23 7:52:04 AM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    Ladenburg Thalmann initiated coverage on Blade Air Mobility with a new price target

    Ladenburg Thalmann initiated coverage of Blade Air Mobility with a rating of Buy and set a new price target of $13.00

    7/17/23 7:20:37 AM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    $BLDE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wiesenthal Robert S was granted 40,607 shares, increasing direct ownership by 0.78% to 5,275,662 units (SEC Form 4)

    4 - Strata Critical Medical, Inc. (0001779128) (Issuer)

    9/3/25 8:43:59 PM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    Chief Accounting Officer Cohen Amir was granted 11,844 shares, increasing direct ownership by 13% to 103,760 units (SEC Form 4)

    4 - Strata Critical Medical, Inc. (0001779128) (Issuer)

    9/3/25 8:23:12 PM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    Director Lauck Andrew was granted 11,844 shares, increasing direct ownership by 10% to 130,642 units (SEC Form 4)

    4 - Strata Critical Medical, Inc. (0001779128) (Issuer)

    9/3/25 8:23:06 PM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    $BLDE
    SEC Filings

    View All

    Blade Air Mobility Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Strata Critical Medical, Inc. (0001779128) (Filer)

    8/29/25 8:31:46 AM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    Amendment: Blade Air Mobility Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K/A - Strata Critical Medical, Inc. (0001779128) (Filer)

    8/29/25 8:29:50 AM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    SEC Form SCHEDULE 13G filed by Blade Air Mobility Inc.

    SCHEDULE 13G - Blade Air Mobility, Inc. (0001779128) (Subject)

    8/11/25 4:32:32 PM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    $BLDE
    Financials

    Live finance-specific insights

    View All

    Blade Air Mobility Announces Second Quarter 2025 Results

    Medical revenue increased 17.6% year-over-year in Q2 2025 Net loss improved by $7.6 million versus the prior year to $(3.7) million in Q2 2025; Adjusted EBITDA improved by $2.2 million versus the prior year to $3.2 million in Q2 2025(1)Blade Passenger division to be sold to Joby Aviation for up to $125 million; Blade's Medical division will remain a standalone public company, rebrand as Strata Critical Medical ("Strata")Sale is expected to be Adjusted EBITDA and Free Cash Flow neutral on a go forward basis NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (NASDAQ:BLDE, ", Blade", or the ", Company", )), today announced financial results for the second quarter e

    8/5/25 7:00:00 AM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    Blade Air Mobility Announces Date for Second Quarter Ending June 30, 2025 Earnings Release Conference Call

    NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (NASDAQ:BLDE, "Blade" or the "Company")), will release financial results for the second quarter ended June 30, 2025 on Tuesday, August 5, 2025 before the market opens. The company will hold a conference call the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Rob Wiesenthal, Blade's Chief Executive Officer, and Will Heyburn, Blade's Chief Financial Officer, and will include a question-and-answer session for call participants. To join the live call, please register here. Upon registration, a dial-in and unique PIN will be provided to join the call. An audio-only webcast of the call may

    7/24/25 8:00:00 AM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    Blade Air Mobility Announces First Quarter 2025 Results

    Net loss improved by $0.7 million versus the prior year to $(3.5) million in Q1 2025; Adjusted EBITDA improved by $2.3 million versus the prior year to $(1.2) million in Q1 2025(1)First Adjusted EBITDA profitable Q1 in the Passenger Segment since going public. Passenger Segment Adjusted EBITDA of $0.1 million in Q1 2025 represents a $2.7 million increase versus the prior year Q1 2025 revenue increased 5.4% versus the prior year to $54.3 million. Excluding Canada, which we exited in August 2024, revenue increased 10.9% versus the prior year period and Passenger Segment revenue increased 42.0% year-over-year(1)Achieved new monthly record for Medical trip volumes in April 2025Reaffirming guidan

    5/12/25 7:00:00 AM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    $BLDE
    Leadership Updates

    Live Leadership Updates

    View All

    Blade Appoints Former Carlson Wagonlit Travel Executive as Blade Europe CEO; Expedited Tarmac-Side Security Screening at France's Nice Int'l Airport for Passengers Launched

    NEW YORK, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (NASDAQ:BLDE, ", Blade", ))) an asset-light passenger air mobility and medical logistics company, today announced the appointment of Rémi Bouysset as CEO of Blade Europe.​​ Blade Europe passengers can now enjoy helipad-side security clearance at Nice International Airport ("Nice Airport"), enabling helicopter fliers to connect directly to their commercial flights at their departing gates, bypassing the general security screening queues at the airport. Mr. Bouysset brings to Blade Europe a wealth of experience spanning 30 years in the travel, hospitality, and luxury sectors. The France-born executive led international c

    2/1/24 8:30:00 AM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    Blade Air Mobility Expands Board of Directors, Appoints Andrew Lauck of RedBird Capital Partners and Technology Executive John Borthwick

    NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- The Board of Directors (the "Board") of Blade Air Mobility, Inc. (NASDAQ:BLDE, ", Blade", or the ", Company", ))), a technology-powered global air mobility platform, today announced the expansion of the Board from seven to nine members, and the appointment of two new directors, Andrew Lauck and John Borthwick. Mr. Lauck, a current Board observer for Blade, will officially join the Board as a director and will serve on the Audit Committee. Mr. Borthwick, a former Board member when Blade was private, will join the Nominating and Corporate Governance Committee. "We are pleased to welcome Andrew and John to our Board of Directors," said Eric Affeld

    3/30/23 4:01:00 PM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    Blade Announces Formation of Blade Europe to Accelerate International Growth

    Appoints Two Industry Leaders to Establish European Presence Blade Air Mobility, Inc. (NASDAQ:BLDE, "Blade" or the "Company"))), a technology-powered global air mobility platform, today announced the creation of Blade Europe and the appointment of Sabrina Barbera as Executive Director of Blade Europe and Anne-Pascale Guedon as Executive Vice President, Business Development, Blade Europe. Blade Europe will be headquartered in Paris, France. Barbera has nearly 20 years of experience in aerospace and aviation and is currently a Vice-President at Airbus Helicopters overseeing their Simulation and Training department that trains over 8,000 pilots and technicians each year. Prior to this positi

    4/20/22 8:00:00 AM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    $BLDE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Blade Air Mobility Inc.

    SC 13G/A - Blade Air Mobility, Inc. (0001779128) (Subject)

    12/10/24 1:28:44 PM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Blade Air Mobility Inc.

    SC 13G/A - Blade Air Mobility, Inc. (0001779128) (Subject)

    11/8/24 2:52:46 PM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Blade Air Mobility Inc.

    SC 13G/A - Blade Air Mobility, Inc. (0001779128) (Subject)

    11/5/24 6:07:26 AM ET
    $BLDE
    Transportation Services
    Consumer Discretionary